Clinical Trial: An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923526) titled 'An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)' on Oct. 19.

Brief Summary: The purpose of this study is to evaluate the long-term impact of treprostinil SMI on safety and efficacy by providing it to PH-COPD patients who participated in a preceding Phase 2 or 3 study.

Study Start Date: March, 2027

Study Type: INTERVENTIONAL

Condition: Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease

Intervention: COMBINATION_PRODUCT: treprostinil SMI (treprostinil inhalation spray)

Inhaled t...